Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa

被引:65
|
作者
Gaziano, T. A. [1 ]
机构
[1] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA
关键词
D O I
10.1136/hrt.2007.128785
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease is the leading cause of death in those over the age of 45 in Africa. The economic toll from cardiovascular diseases is equally devastating, leading to billions of dollars lost due to healthcare costs and reduced productivity from the disabling and fatal outcomes related to diabetes, hypertension, stroke, valvular heart disease, and heart failure. Much of it is preventable. With reasonable screening programmes and judicious use of scarce resources much of the suffering can be alleviated. This article reviews the economic burden attributable to cardiovascular disease in Africa and many of the potential cost-effective solutions to the large burden. It further outlines many of the areas where we know less and must focus our future research in trying to outline cost-effective solutions.
引用
收藏
页码:140 / 144
页数:5
相关论文
共 50 条
  • [1] The economic burden of depression and the cost-effectiveness of treatment
    Wang, PS
    Simon, G
    Kessler, RC
    [J]. INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH, 2003, 12 (01) : 22 - 33
  • [2] Cost-Effectiveness and Economic Burden of PCI
    Iantorno, Micaela
    Weintraub, William S.
    [J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2018, 19 (05) : 561 - 563
  • [3] The burden of AS and the cost-effectiveness of treatment.
    Kobelt, G
    Andlin-Sobocki, P
    Jönsson, L
    Brophy, S
    Calin, A
    Braun, J
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S658 - S658
  • [4] Economic Burden Associated with the Treatment with a Cardiovascular Polypill in Secondary Prevention in Spain: Cost-Effectiveness Results of the NEPTUNO Study
    Cordero, Alberto
    Gonzalez-Gallarza, Regina Dalmau
    Masana, Lluis
    Fuster, Valentin
    Castellano, Jose Ma
    Olivar, Jose Emilio Ruiz
    Zsolt, Ilonka
    Sicras-Mainar, Antoni
    Juanatey, Jose Ramon Gonzalez
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2023, 15 : 559 - 571
  • [5] Treating hypertension - Effect of treatment and cost-effectiveness in respect to later cardiovascular diseases
    Hedner, T
    [J]. SCANDINAVIAN CARDIOVASCULAR JOURNAL, 1998, 32 : 31 - 35
  • [6] Cost-effectiveness of primary and secondary prevention in cardiovascular diseases
    Troche, CJ
    Tacke, J
    Hinzpeter, B
    Danner, M
    Lauterbach, KW
    [J]. EUROPEAN HEART JOURNAL, 1998, 19 : C59 - C65
  • [7] Cost-Effectiveness of Population-Based Tobacco Control Interventions on the Health Burden of Cardiovascular Diseases in Vietnam
    Duyen Thuy Nguyen
    Khue Ngoc Luong
    Hai Thi Phan
    Anh Tuan Tran
    Son The Dao
    Poudel, Ak Narayan
    Thang Manh Hoang
    Vuong Van Do
    Dat Minh Le
    Giang Huong Pham
    Linh Thuy Nguyen
    Anh Tu Duong
    Minh Van Hoang
    [J]. ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, 2021, 33 (08) : 854 - 860
  • [8] Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases
    Zhu, Ye
    Swanson, Kristi M.
    Rojas, Ricardo L.
    Wang, Zhen
    St. Sauver, Jennifer L.
    Visscher, Sue L.
    Prokop, Larry J.
    Bielinski, Suzette J.
    Wang, Liewei
    Weinshilboum, Richard
    Borah, Bijan J.
    [J]. GENETICS IN MEDICINE, 2020, 22 (03) : 475 - 486
  • [9] Prevention of cardiovascular diseases in Nairobi slums: a cost-effectiveness study
    van de Vijver, Steven
    Oti, Samuel
    Gomez, Gabriela B.
    Agyemang, Charles
    Lange, Joep
    Kyobutungi, Catherine
    [J]. LANCET, 2014, 384 : S12 - S12
  • [10] The burden of malaria epidemics and cost-effectiveness of interventions in epidemic situations in Africa
    Worrall, E
    Rietveld, A
    Delacollette, C
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2004, 71 (02): : 136 - 140